Differential effects of μ-, δ, and κ-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat

Journal of Neurophysiology

Volumn 83, Issue 4, 2000, Pages 2209-2216

  Ozaki, Noriyuki ^a   Sengupta, J N ^a,b   Gebhart, G F ^a  

^a UNIVERSITY OF IOWA   (United States)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

4 [ALPHA (4 ALLYL 2,5 DIMETHYL 1 PIPERAZINYL) 3 METHOXYBENZYL] N,N DIETHYLBENZAMIDE; ASIMADOLINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NORBINALTORPHIMINE; OPIATE AGONIST; SPIRADOLINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; MECHANICAL STIMULATION; NERVE CELL INHIBITION; NERVE CELL MEMBRANE STEADY POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; STOMACH DISTENSION; STOMACH INNERVATION; VAGUS NERVE STIMULATION;

EID: 0034111874     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.2000.83.4.2209     Document Type: Article

References (51)

1. ALZHEIMER, C. AND TEN BRUGGENCATE, G. Nonopioid actions of the κ-opioid receptor agonists, U50488H and U69593, on electrophysiologic properties of hippocampal CA3 neurons in vitro. J. Pharmacol. Exp. Ther. 255: 900-905, 1990.
2. ANDREEV, N., URBAN, L., AND DRAY, A. Opioids suppress spontaneous activity of polymodal nociceptors in rat paw skin induced by ultraviolet irradiation. Neuroscience 58: 793-798, 1994.
3. BALKOWIEC, A., KUKULA, K., AND SZULCZYK, P. Influence of morphine on the activity of low-threshold visceral mechanoreceptors in cats with acute pericarditis. Pain 59: 251-259, 1994.
4. BINDER, W. AND WALKER, J. Effect of peripherally selective κ-opioid agonist, asimadoline, on adjuvant arthritis. Br. J. Pharmacol. 124: 647-654, 1998.
5. BURTON, M. B. AND GEBHART, G. F. Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation. J. Pharmacol. Exp. Ther. 285: 707-715, 1998.
6. 2 opioid binding sites in rats, guinea pigs, monkeys and humans. NeuroReport 9: 2523-2525, 1998.
7. 3 subtype. J. Pharmacol. Exp. Ther. 251: 461-468, 1989.
8. CRAIN, S. M. AND SHEN, K.-F. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11: 77-81, 1990.
9. DANZEBRINK, R. M., GREEN, S. A., AND GEBHART, G. F. Spinal mu and delta, but not kappa, opioid-receptor agonists attenuate responses to noxious colorectal distension in the rat. Pain 63: 39-47, 1995.
10. 1-13 and U69,593 in the rat brain. J. Pharmacol. Exp. Ther. 253: 749-759, 1990.
11. DIOP, L., RIVIÉRE, P.J.M., PASCAUD, X., DASSAUD, M., AND JUNIEN, J.-L. Role of vagal afferents in the antinociception produced by morphine and U-50,488H in the colonic pain reflex in rats. Eur. J. Pharmacol. 257: 181-187, 1994.
12. EASTWOOD, C. AND GRUNDY, D. Morphine stimulates intestinal afferent discharge via μ- and δ-, but not κ-opioid receptors (Abstract). Gastroenterology 108: A594, 1995.
13. + currents in F11 neuroblastoma x DRG neuron hybrid cells via cholera toxin-sensitive receptors. Brain Res. 605: 214-220, 1993.
14. GEBHART, G. F. AND SENGUPTA, J. N. Evaluation of visceral pain. In: Handbook of Methods in Gastrointestinal Pharmacology, edited by T. S. Gaginella. Boca Raton, FL: CRC, 1996, p. 359-373.
15. 5] enkephalin or intravenous U50,488H on the visceromotor response to colorectal distension in the rat. Anesthesiology 83: 336-343, 1995.
16. HERRERO, J. F. AND HEADLEY, P. M. Functional evidence for multiple receptor activation by κ-ligands in the inhibition of spinal nociceptive reflexes in the rat. Br. J. Pharmacol. 110: 303-309, 1993.
17. HO, J., MANNES, A. J., DUBNER, R., AND CAUDLE, R. M. Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation. J. Pharmacol. Exp. Ther. 281: 136-141, 1997.
18. HUNTER, J. C., LEIGHTON, G. E., MEECHAM, K. G., BOYLE, S. J., HORWELL, D. C., REES, D. C., AND HUGHES, J. CI-977, a novel and selective agonist for the κ-opioid receptor. Br. J. Pharmacol. 101: 183-189, 1990.
19. KUMAZAWA, T., MIZUMURA, K., SATO, J., AND MINAGAWA, M. Facilitatory effects of opioids on the discharges of visceral nociceptors. Brain Res. 497: 231-238, 1989.
20. 1b subtype. NeuroReport 5: 2161-2164, 1994.
21. MEUNIER, J.-C. Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor. Eur. J. Pharmacol. 340: 1-15, 1997.
22. 1 receptor. Nature 377: 532-535, 1995.
23. NESS, T. J. Kappa opioid receptor agonists differentially inhibit two classes of rat spinal neurons excited by colorectal distension. Gastroenterology 117: 388-394, 1999.
24. NESS, T. J. AND GEBHART, G. F. Colorectal distension as a noxious visceral stimulus: physiologic and pharmacologic characterization of pseudaffective reflexes in the rat. Brain Res. 450: 153-169, 1988.
25. OZAKI, N., SENGUPTA, J. N., AND GEBHART, G. F. Effect of platelet activating factor on gastric vagal afferent fibers in the rat. Soc. Neurosci. Abstr. 24: 1623, 1998.
26. OZAKI, N., SENGUPTA, J. N., AND GEBHART, G. F. Mechanosensitive properties of gastric vagal afferent fibers in the rat. J. Neurophysiol. 82: 2210-2220, 1999.
27. PASTERNAK, K. R., ROSSI, G. C., ZUCKERMAN, A., AND PASTERNAK, G. W. Antisense mapping KOR-1: evidence for multiple kappa analgesic mechanisms. Brain Res. 826: 289-292, 1999.
28. PAUL, D., LEVISON, J. A., HOWARD, D. H., PICK, C. G., HAHN, E. F., AND PASTERNAK, G. W. Naloxone benzoylhydrazone (NalBzoH) analgesia. J. Pharmacol. Exp. Ther. 255: 769-774, 1990.
29. + channel blocking actions of the novel class I anti-arrhythmic agent RSD 921. Br. J. Pharmacol. 127: 9-18, 1999.
30. PUGSLEY, M. K., PENZ, M. P., WALKER, M.J.A., AND WONG, T. M. Cardiovascular actions of the κ-agonist, U-50,488H, in the absence and presence of opioid receptor blockade. Br. J. Pharmacol. 105: 521-526, 1992.
31. PUGSLEY, M. K., SAINT, D. A., PENZ, M. P., AND WALKER, M.J.A. Electrophysiological and antiarrhythmic actions of the κ agonist PD 129290 and its. R, R (+)-enantiomer, PD 129289. Br. J. Pharmacol. 110: 1579-1585, 1993.
32. RANDICH, A. AND GEBHART, G. F. Vagal afferent modulation of nociception. Brain Res. Rev. 17: 77-99, 1992.
33. RANDICH, A., THURSTON, C. L., LUDWIG, P. S., TIMMERMAN, M. R., AND GEBHART, G. F. Antinociception and cardiovascular responses produced by intravenous morphine: the role of vagal afferents. Brain Res. 543: 256-270, 1991.
34. REINSCHEID, R. K., NOTHACKER, H.-P., BOURSON, A., ARDATI, A., HENNINGSEN, R. A., BUNZOW, J. R., GRANDY, D. K., LANGEN, H., MONSMA, F. J., JR., AND CIVELLI, O. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science 270: 792-794, 1995.
35. ROTHMAN, R. B., BYKOV, V., DE COSTA, B. R., JACOBSON, A. E., RICE, K. C., AND BRADY, L. S. Interaction of endogenous opioid peptides and other drugs with four kappa opioid binding sites in guinea pig brain. Peptides 11: 311-331, 1990.
36. RUSSELL, N.J.W., SCHAIBLE, H.-G., AND SCHMIDT, R. F. Opiates inhibit the discharges of fine afferent units from inflamed knee joint of the cat. Neurosci. Lett. 76: 107-112, 1987.
37. SENGUPTA, J. N., OZAKI, N., AND GEBHART, G. F. Differential effects of μ- and κ-opioid receptor agonists on responses of gastric vagal afferent fibers in the rat. Soc. Neurosci. Abstr. 23: 1002, 1997.
38. SENGUPTA, J. N., SNIDER, A., SU, X., AND GEBHART, G. F. Effects of kappa opioids in the inflamed rat colon. Pain 79: 175-185, 1999.
39. SENGUPTA, J. N., SU, X., AND GEBHART, G. F. κ, but not μ or δ, opioids attenuate responses to distention of afferent fibers innervating the rat colon. Gastroenterology 111: 968-980, 1996.
40. SHEN, K.-F. AND CRAIN, S. M. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 491: 227-242, 1989.
41. SHEN, K.-F. AND CRAIN, S. M. Nerve growth factor rapidly prolongs the action potential of mature sensory ganglion neurons in culture, and this effect requires activation of Gs-coupled excitatory κ-opioid receptors on these cells. J. Neurosci. 14: 5570-5579, 1994a.
42. SHEN, K.-F. AND CRAIN, S. M. Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence. Brain Res. 636: 286-297, 1994b.
43. SPANAGEL, R., ALMEIDA, O.F.X., AND SHIPPENBERG, T. S. Evidence that norbinaltorphimine can function as an antagonist at multiple opioid receptor subtypes. Eur. J. Pharmacol. 264: 157-162, 1994.
44. SU, X., SENGUPTA, J. N., AND GEBHART, G. F. Effects of opioids on mechano-sensitive pelvic nerve afferent fibers innervating the urinary bladder of the rat. J. Neurophysiol. 77: 1566-1580, 1997a.
45. SU, X., SENGUPTA, J. N., AND GEBHART, G. F. Effects of kappa opioid receptor-selective agonists on responses of pelvic nerve afferents to noxious colorectal distension. J. Neurophysiol. 78: 1003-1012, 1997b.
46. SU, X., WACHTEL, R. E., AND GEBHART, G. F. Inhibition of calcium currents in rat colon sensory neurons by κ-but not μ- or δ-opioids. J. Neurophysiol. 80: 3112-3119, 1998.
47. TALLARIDA, R. J. AND MURRAY, R. B. Manual of Pharmacologic Calculations With Computer Programs (2nd ed.). New York: Springer-Verlag, 1987.
48. TAKEMORI, A. E., HO, B. Y., NAESETH, J. S., AND PORTOGHESE, P. S. Norbinaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays. J. Pharmacol. Exp. Ther. 246: 255-258, 1988.
49. ZHU, Y. AND IM, W. B. Block of sodium channel current by anticonvulsant U-54494A in mouse neuroblastoma cells. J. Pharmacol Exp. Ther. 260: 110-116, 1992.
50. ZHU, Y., IM, W. B., LEWIS, R. A., AND VON VOIGTLANDER, P. F. Comparison of pyrrolidinyl and piperidinyl benzamides for their anticonvulsant activity and inhibitory action on sodium channel. Br. J. Pharmacol. 106: 49-54, 1992.
51. 2 opioid receptors. Proc. Natl. Acad. Sci. USA 85: 4061-4065, 1988.